Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4401
State Street Health Care Select Sector SPDR ETF
XLV
$43.8B
| $1.07M | ﹤0.01% |
12,994
-183,149
| -93% | -$15.1M |
|
|
AXDX
4402
PUT
DELISTED
Accelerate Diagnostics
AXDX
| $1.07M | ﹤0.01% |
4,090
+1,900
| +87% | +$445K |
|
4403
CALL
Graco
GGG
$13.3B
| $1.07M | ﹤0.01% |
23,700
+9,300
| +65% | +$403K |
|
|
BUFF
4404
CALL
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $1.07M | ﹤0.01% |
32,700
+14,100
| +76% | +$418K |
|
4405
Pathward Financial
CASH
$1.8B
| $1.07M | ﹤0.01% |
+34,620
| New | +$1M |
|
|
WAIR
4406
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $1.07M | ﹤0.01% |
144,545
+80,979
| +127% | +$670K |
|
|
SONC
4407
PUT
DELISTED
Sonic Corp
SONC
| $1.07M | ﹤0.01% |
38,900
+5,600
| +17% | +$144K |
|
4408
Perdoceo Education
PRDO
$2B
| $1.07M | ﹤0.01% |
88,256
+51,970
| +143% | +$618K |
|
4409
Financial Institutions
FISI
$823M
| $1.06M | ﹤0.01% |
34,243
-60,377
| -64% | -$1.9M |
|
4410
SandRidge Energy
SD
$520M
| $1.06M | ﹤0.01% |
+50,554
| New | +$942K |
|
|
HSII
4411
DELISTED
Heidrick & Struggles
HSII
| $1.06M | ﹤0.01% |
43,345
-6,542
| -13% | -$153K |
|
4412
MacroGenics
MGNX
$269M
| $1.06M | ﹤0.01% |
56,029
-29,898
| -35% | -$558K |
|
|
TGB
4413
Trekor Metals
TGB
$3.06B
| $1.06M | ﹤0.01% |
455,894
+381,368
| +512% | +$826K |
|
|
PTVCB
4414
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $1.06M | ﹤0.01% |
44,325
-5,796
| -12% | -$135K |
|
|
DCP
4415
PUT
DELISTED
DCP Midstream, LP
DCP
| $1.06M | ﹤0.01% |
29,200
+14,100
| +93% | +$491K |
|
4416
Copa Holdings
CPA
$6.14B
| $1.06M | ﹤0.01% |
7,904
+5,105
| +182% | +$664K |
|
4417
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.42B
| $1.06M | ﹤0.01% |
+17,317
| New | +$1.04M |
|
4418
PUT
United Natural Foods
UNFI
$2.93B
| $1.06M | ﹤0.01% |
21,500
-9,800
| -31% | -$428K |
|
4419
PUT
Ziff Davis
ZD
$1.9B
| $1.06M | ﹤0.01% |
16,215
+5,175
| +47% | +$337K |
|
4420
Workiva
WK
$3.84B
| $1.06M | ﹤0.01% |
49,333
+23,304
| +90% | +$513K |
|
|
IPXL
4421
CALL
DELISTED
Impax Laboratories, Inc.
IPXL
| $1.06M | ﹤0.01% |
63,400
+34,700
| +121% | +$636K |
|
4422
PUT
Ligand Pharmaceuticals
LGND
$5.87B
| $1.05M | ﹤0.01% |
12,343
+2,725
| +28% | +$236K |
|
4423
Alaunos Therapeutics
TCRT
$4.71M
| $1.05M | ﹤0.01% |
1,697
+520
| +44% | +$374K |
|
4424
CALL
Crane NXT
CXT
$2.97B
| $1.05M | ﹤0.01% |
33,972
+22,168
| +188% | +$648K |
|
4425
PUT
Flowserve
FLS
$10.3B
| $1.05M | ﹤0.01% |
25,000
+11,400
| +84% | +$477K |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.